NASDAQ
Bioventus Inc. - Class A (BVS)
♥ 538 Thanks from members
Bioventus Inc. (BVS) exhibits positive financial momentum with Q2 2026 revenue of $153.2 million, beating EPS estimates at $0.22, and reaffirming full-year guidance while initiating a strategic alternatives review.